Replies to post #2421 on Immunotech Laboratories Inc (IMMB)

[NanoEE]

Too much money wrapped up into the “Lab” that was suppose to be producing ImmunH(ITV-1).

Had to make it worth while his adventure(because of the amount of shares HZ has) and the availability/readiness of the Bulgarian Lab(although I don’t think it’s actually in Bulgaria, or is it?!?!).

[Dodgeball]

Meanwhile, Dimitar is organizing shareholders to bring $IMMB current.

From the Immunotech Laboratories BG Facebook page:

TO THE SHAREHOLDERS OF IMMUNOTECH LABORATORIES INC. (IMMB)
Dear shareholders in Immunotech Laboratories Inc. (IMMB),
For more than 5 years, the CEO of IMMB, Harry Zhabilov, has not organized the mandatory yearly shareholders meetings, has not made yearly balances of the company and has not conducted an audit of the company on purpose. I, Dimitar Savov, who own more than 15% in IMMB and am a majority shareholder in Immunotech Laboratories BG, believe that Zhabilov is purposefully leading IMMB towards bankruptcy in order to transfer its assets to a different company where he has more shares. All of us, the shareholders in IMMB, must unite and conduct a yearly shareholder meeting in order to elect a new board of directors. IMMB has an immense potential for profit and dividends, because the company owns 49% in Immunotech Laboratories BG; this means that IMMB will receive 49% of the profits from the sale of ITV-1, a medicinal product, which we have clinically tested for AIDS in Bulgaria (EU) and has shown very good treatment effect. Immunotech Laboratories BG has signed long-term agreements with many big partners for the sale of millions of sets of ITV-1 for countries like Ukraine, Greece, Romania, Turkey, and others. The average profit per set of ITV-1 will be 1500 EUR, which means profits in billions.
I ask for all shareholders in IMMB to contact us on [e-mail] so we can coordinate our actions and bring IMMB to current status.
With respect,
Dimitar Savov
President of Immunotech Laboratories BG